A New Twist on an Old Problem
- 1 January 2009
- journal article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 28 (1) , 74-75
- https://doi.org/10.1097/inf.0b013e31818bfeb4
Abstract
Recent studies show that multidrug-resistant Streptococcus pneumoniae serotype 19A continues to emerge as a cause of invasive pneumococcal disease after the introduction of Prevnar. We report a case of multidrug-resistant S. pneumoniae serotype 19A meningitis successfully treated with vancomycin and levofloxacin. This case reinforces the need for the empiric use of vancomycin in meningitis and the need for alternative treatments.Keywords
This publication has 6 references indexed in Scilit:
- Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005The Journal of Infectious Diseases, 2008
- Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004The Journal of Infectious Diseases, 2007
- Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-ResistantStreptococcus pneumoniaeNew England Journal of Medicine, 2006
- Practice Guidelines for the Management of Bacterial MeningitisClinical Infectious Diseases, 2004
- Pharmacodynamics of Gatifloxacin in Experimental Models of Pneumococcal MeningitisClinical Infectious Diseases, 2000
- Antibiotic Pharmacodynamics in Cerebrospinal FluidClinical Infectious Diseases, 1998